HydroxycarbamideLack of efficacy: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1853卷 / 1期

关键词：

D O I：

10.1007/s40278-021-95094-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：228 / 228

相关论文

共 50 条

[31] InfliximabLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1954 (1) : 252 - 252
[32] DapagliflozinLack of efficacy: 5 case reports
Reactions Weekly, 2025, 2040 (1) : 289 - 289
[33] AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1931 (1) : 71 - 71
[34] TacrolimusLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1940 (1) : 387 - 387
[35] AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1916 (1) : 46 - 46
[36] AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1943 (1) : 90 - 90
[37] ImmunosuppressantsLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1944 (1) : 309 - 309
[38] CatequentinibLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1939 (1) : 131 - 131
[39] VismodegibLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1946 (1) : 538 - 538
[40] MethotrexateLack of efficacy: 5 case reports
Reactions Weekly, 2025, 2060 (1) : 205 - 205

← 1 2 3 4 5 →